M&A Deal Summary

Bayer Acquires Boehringer Ingelheim Vetmedica - Cydectin

On January 4, 2017, Bayer acquired life science company Boehringer Ingelheim Vetmedica - Cydectin from Boehringer Ingelheim Vetmedica

Acquisition Highlights
  • This is Bayer’s 4th transaction in the Life Science sector.
  • This is Bayer’s 5th transaction in the United States.
  • This is Bayer’s 1st transaction in Montana.

M&A Deal Summary
Date 2017-01-04
Target Boehringer Ingelheim Vetmedica - Cydectin
Sector Life Science
Buyer(s) Bayer
Sellers(s) Boehringer Ingelheim Vetmedica
Deal Type Divestiture

Target

Boehringer Ingelheim Vetmedica - Cydectin

St. Joseph, Montana, United States
Boehringer Ingelheim Vetmedica, Inc. - Cydectin includes CYDECTIN Pour-On, CYDECTIN Injectable and CYDECTIN Oral Drench. These endectocides with the active ingredient moxidectin offer persistent killing of internal parasites at multiple stages, including the most economically devastating parasite, Ostertagia ostertagi (brown stomach worm) and controls external parasites including lice, grubs and psoroptic mange mites on beef and dairy cattle.

Search 193,724 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Bayer

Leverkusen, Germany

website

Category Company
Founded 1863
Sector Life Science
Employees99,349
Revenue 50.7B EUR (2022)
DESCRIPTION
Bayer office building in North Sydney, Australia.
Bayer office building in North Sydney, Australia.

Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech polymer materials. As an innovation company, it sets trends in research-intensive areas. Bayer’s products and services are designed to benefit people and improve the quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer was founded in 1863 and is based in Leverkusen, Germany.

DEAL STATS #
Overall 13 of 19
Sector (Life Science) 4 of 9
Type (Divestiture) 2 of 2
State (Montana) 1 of 1
Country (United States) 5 of 9
Year (2017) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-09-14 Monsanto

St. Louis, Missouri, United States

Monsanto Co. is a chemical and agricultural biotechnology company offering farmers a wide range of corn, soybean, cotton, wheat, canola, sorghum and sugar cane seeds. Monsanto was formed in 2000 and is based in St. Louis, Missouri.

Buy $66.0B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-01-05 Bayer AG - Serdex

Leverkusen, Germany

Bayer AG - Serdex is a specialist of botanical active ingredients for dermo-cosmetics and skin treatment.

Sell -

Seller(S) 1

SELLER

Boehringer Ingelheim Vetmedica

St. Joseph, Montana, United States

website

Category Company
Founded 1917
Sector Life Science
DESCRIPTION

Boehringer Ingelheim Vetmedica, Inc. is a developer of innovative vaccines and pharmaceuticals with the highest therapeutic value in the cattle, equine, pet and swine markets.

DEAL STATS #
Overall 2 of 2
Sector (Life Science) 2 of 2
Type (Divestiture) 2 of 2
State (Montana) 2 of 2
Country (United States) 2 of 2
Year (2017) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-10-05 Boehringer Ingelheim Vetmedica - U.S. Feline Canine and Rabies Vaccines

St. Joseph, Montana, United States

Boehringer Ingelheim Vetmedica, Inc. - U.S. Feline, Canine and Rabies Vaccines is a developer of vaccines for animals. The business also inculded fully integrated manufacturing and R&D site.

Sell $885M
Mergr

Product

Company

Legal